GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93023C00033MOLECULAR EXPRESS, INC

Overview

Award facts

Net obligations
$599.93K
$599,925of $3.60M potential value
Outlays (paid to date)
$474.92K
$474.92K paid of $599.93K obligated$474,924
Period of performance
Sep 30, 2023 to Apr 10, 2025
Ended
Modifications
1
Latest action Apr 10, 2025
Contract type
Definitive contract
PIID 75N93023C00033

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

DEVELOPMENT OF VESIVAX CO-ADJUVANT FORMULATION OF 2E151.

Dates and value

Award date
Signed on Aug 29, 2023
Potential end of performance
Sep 28, 2028
Current value
$599,925Base and exercised options
Potential value (if all options are exercised)
$3,599,784

Obligations by fiscal year of action

  • FY2023: $599,925

Total across 1 fiscal year: $599,925

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 10, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationRANCHO DOMINGUEZ, CA
UEIR1JMHFESEKD5
CAGE code337D8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Compton, Los Angeles County, California 90220-5610
Congressional district (place of performance)
CA-44As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
10

Solicitation and notices

Solicitation ID
PHS2023-01(as reported)
Solicitation date
Aug 8, 2022

Contract details

Subcontracting plan
Plan not included - no subcontracting possibilitiesA
Major program
Development of vesivax co-adjuvant formulation of 2E151.
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 29, 2023Base obligation at award: $599,925
Latest action
Apr 10, 2025 — Terminated for convenienceModification P00001
Latest substantive action
Apr 10, 2025 — Terminated for convenienceModification P00001
Actions by type
  • Base award1
  • Terminated for convenience1
2 actions recorded, Aug 29, 2023 to Apr 10, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2023/2023-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression